3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
11
Papillomavirus Infections
5
Uterine Cervical Dysplasia
4
Uterine Cervical Diseases
2
Squamous Intraepithelial Lesions
2
Precancerous Conditions
2
Genital Diseases
2
Atypical Squamous Cells of the Cervix
2
Uterine Neoplasms
1
Uterine Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Sexually Transmitted Diseases, Viral
1
Sexually Transmitted Diseases
1
Neoplasms by Site
1
Neoplasms
1
HIV Infections
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Female Urogenital Diseases and Pregnancy Complications
1
Acquired Immunodeficiency Syndrome
1
Interventions
Standard of Care
2
Methods
2
Interviews as Topic
2
Educational Status
2
Early Intervention, Educational
2
relacorilant
1
nilotinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Radiotherapy
1
Pregnancy Tests
1
Practice Guidelines as Topic
1
Paclitaxel
1
Nivolumab
1
Laparoscopy
1
Ipilimumab
1
Human Papillomavirus DNA Tests
1
Fulvestrant
1
Electrocardiography
1
Colposcopy
1
Cell Count
1
Biopsy
1
Bevacizumab
1
Behavior Therapy
1
Acetic Acid
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genital Neoplasms, Female
×
Colposcopy
×
1 year
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled